We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Researchers Find Location of Pancreatic Cancer Gene

By Biotechdaily staff writers
Posted on 21 May 2002
A team of researchers has mapped the location of a gene associated with inherited pancreatic cancer to a large region called 4q32-34, and they expect to have the gene sequenced within a year. More...
Finding the gene will open new avenues for preventing, detecting, and treating the disease. The research appears in the early electronic edition of the April 2002 issue of the American Journal of Human Genetics.

Gathering sufficient genetic data was aided by the cooperation of Family X, the largest pancreatic-cancer family ever studied. Of the 20 family members affected (18 with pancreatic cancer or precancerous changes), nine have died of the disease, including five of six brothers. After genotyping the DNA samples from Family X, the researchers found that virtually every member of the family had a specific genetic marker on the long arm of chromosome 4, where the single-gene mutation responsible for pancreatic cancer is thought to be. None of the unaffected family members had this marker. Inherited pancreatic cancer accounts for about 10% of all cases.

The investigators were from the Fred Hutchinson Cancer Research Center (Seattle, WA. USA), the University of Washington School of Medicine (Seattle), and the University of Pittsburgh School of Medicine (PA, USA).

"Once the actual gene is found, if it turns out to be commonly mutated in all forms of pancreatic cancer—not just the inherited type—it could be used as a marker for broad screening,” said Leonid Kruglyak, Ph.D., a statistical geneticist at Fred Hutchinson. "Knowing and understanding the gene's pathways to cancer also could lead to new therapeutic developments.”





Related Links:
Fred Hutchinson
Univ. of Washington
Univ. of Pittsburgh

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.